JPRN-UMIN000019594Completed未知
Quinidine sulfate administration for intractable epilepsy with KCNT1 gene mutation - Quinidine sulfate administration for intractable epilepsy with KCNT1 gene mutation
HO, National Epilepsy Center, Shizuoka Institute of Epilepsy and Neurological Disorders0 sites10 target enrollmentStarted: November 2, 2015Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 10
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- ot applicable to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •The patient who is judged by the patient's physician as unsuitable for participating in this study.
Investigators
Similar Trials
Completed
Not Applicable
Efficacy and safety of injectable quinine for the treatment of malaria in JapamalariaJPRN-UMIN000027485niversity of Miyazaki33
Recruiting
Not Applicable
Role of oral Coenzyme Q supplementation in children with migraineCTRI/2020/07/026271ICMR
Not yet recruiting
Not Applicable
Observation for the clinical effect of compound Qihuo tablet in the treatment of elderly osteoporotic low back paiITMCTR2000003570onghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Active, not recruiting
Not Applicable
Ketoprofen TDS patch Keofix in the treatment of flare-ups of non articular rheumatisms. A double blind, double dummy study vs oral ketoprofen retard 200 mg capsulesEUCTR2004-002856-32-ITZAMBON GROUP130
Withdrawn
Phase 4
Clinical investigation of the Qmedics EXIST NiTi Stent type Flex & Pull in adults with Peripheral Artery Disease (PAD) (of the Q-medics NiTi Stent Family.NL-OMON52001QMedics AG50